Clinically, overexpression of lncRNAs, like MALAT1, HOTAIR, H19, and UCA1, is associated with lymph node metastasis, advanced staging, and poor survival, making them promising biomarkers and therapeutic targets for managing aggressive HNSCC. The gene discussed is H19; the disease is head and neck squamous cell carcinoma.